While the results could suggest that whole-body BCKDK inhibition cannot be reproduced by Bckdk ablation in individual tissues, they perhaps also suggest an alternative mechanism by which BT2 confers protection from heart failure and metabolic disease distinct from BCAA oxidation. This evidence concerns the gene BCKDK and metabolic disease.